Kuros Biosciences AG (SWX:KURN)
Switzerland
· Delayed Price · Currency is CHF 18.20
+0.14 (0.78%)
Apr 4, 2025, 10:45 AM CET
Kuros Biosciences AG Revenue
In the year 2024, Kuros Biosciences AG had annual revenue of 75.56M CHF with 125.11% growth.
Revenue
75.56M
Revenue Growth
+179.89%
P/S Ratio
8.89
Revenue / Employee
619.30K
Employees
122
Market Cap
685.56M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 75.56M | 41.99M | 125.11% |
| Dec 31, 2023 | 33.56M | 15.58M | 86.61% |
| Dec 31, 2022 | 17.99M | 4.17M | 30.19% |
| Dec 31, 2021 | 13.82M | 9.78M | 242.04% |
| Dec 31, 2020 | 4.04M | 1.48M | 57.71% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Roche Holding AG | 62.40B |
| Novartis AG | 46.87B |
| Lonza Group AG | 6.57B |
| Alcon | 8.98B |
| Galderma Group AG | 4.02B |
| Straumann Holding AG | 2.50B |
| Sandoz Group AG | 9.41B |
| Sonova Holding AG | 3.71B |